TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34183794

Group type: EXPERIMENTAL
Intervention: Lid wipes (LWs) containing terpinen‐4‐ol and sodium hyaluronate (Hy‐ter®)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Baby shampoo (BS)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Lid wipes (LWs)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Both LWs and BS
Number of subjects: 48
Study: 34099779

Group type: EXPERIMENTAL
Intervention: Populations of B. pendula on post-industrial wastelands
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Zinc-lead heaps
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Soil parameters (potassium and phosphorus content)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Seedlings from heaps (local gene resources)
Number of subjects: 3
Study: 35682232

Group type: EXPERIMENTAL
Intervention: RNC + Exercise
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: RNC
Number of subjects: 27

Group type: COMPARATOR
Intervention: Usual nicotine cigarettes (Control)
Number of subjects: 27
Study: 36287272

Group type: COMPARATOR
Intervention: Fluoride varnish containing 22.600 fluoride ppm and tricalcium phosphate
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Self-assembling peptides
Number of subjects: 58

Group type: COMPARATOR
Intervention: Fluoride varnish
Number of subjects: 58
Study: 34352943

Group type: EXPERIMENTAL
Intervention: Ablative CO2 fractional laser (ACFL) treatment
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control (untreated scar)
Number of subjects: 15
Study: 36192291

Group type: EXPERIMENTAL
Intervention: Erector spinae plane block (ESB)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Thoracic paravertebral block (TPVB)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Serratus anterior plane block (SAPB)
Number of subjects: 90
Study: 32401286

Group type: EXPERIMENTAL
Intervention: Internet-delivered CBT
Number of subjects: 204

Group type: COMPARATOR
Intervention: Face-to-face CBT
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 204
Study: 34607144

Group type: EXPERIMENTAL
Intervention: Ethanol (group E, n = 9)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Botulinum toxin type A (BTX‐A, group B, n = 9)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Saline (group S, n = 9)
Number of subjects: 27
Study: 33541330

Group type: EXPERIMENTAL
Intervention: SBS & CBL method
Number of subjects: 59

Group type: COMPARATOR
Intervention: LBL & CBL method
Number of subjects: 59
Study: 32069513

Group type: EXPERIMENTAL
Intervention: Internet- and mobile-based interventions (IMIs)
Number of subjects: 0
Study: 34983126

Group type: EXPERIMENTAL
Intervention: Adjuvant oral therapy with tadalafil 5 mg and L-arginine 2,500 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low-intensity extracorporeal shock wave therapy (Li-ESWT) alone
Number of subjects: 0
Study: 34004347

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Pain Psychoeducation (EDU)
Number of subjects: 225

Group type: COMPARATOR
Intervention: Usual Medical Care (UC)
Number of subjects: 225
Study: 32471390

Group type: EXPERIMENTAL
Intervention: Individualized rehabilitation plan created with a dedicated research nurse based on an evidence‐based decision support tool.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 0
Study: 33736846

Group type: EXPERIMENTAL
Intervention: Forensic evidence (DNA, fingerprint)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Forensic evidence (DNA)
Number of subjects: 0
Study: 32050979

Group type: EXPERIMENTAL
Intervention: 'large-normal' portion size (747 kcal)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 'small-normal' portion size (543 kcal)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 'smaller than normal' portion size (339 kcal)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Reduction to portion sizes
Number of subjects: 30
Study: 35557376

Group type: COMPARATOR
Intervention: WALK (walking at 30% VO2 max for 30 min)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: WALK+COG (walking at 30% VO2 max for 30 min while completing N‐back cognitive tasks)
Number of subjects: 10
Study: 33743199

Group type: EXPERIMENTAL
Intervention: BiOC service
Number of subjects: 1422

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 1422
Study: 34239883

Group type: COMPARATOR
Intervention: Bilateral alternating CAM (CAMbi)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Unilateral CAM of the operated leg (CAMuni)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Both CAM groups (CAMuni and CAMbi)
Number of subjects: 85
Study: 32088018

Group type: EXPERIMENTAL
Intervention: Oral rotavirus vaccine (RVV)
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Higher length-for-age Z-score (LAZ) around the time of vaccination
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Concurrent administration of OPV and RVV
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Higher LAZ score post-vaccination
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Higher birthweight
Number of subjects: 219
Study: 35283046

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (2000 IU/day)
Number of subjects: 248

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 248
Study: 35441470

Group type: EXPERIMENTAL
Intervention: semaglutide 2.4 mg
Number of subjects: 1961

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 1961
Study: 33992607

Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan (target dose of 400 mg daily)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Enalapril (target dose of 40 mg daily)
Number of subjects: 52
Study: 32138707

Group type: EXPERIMENTAL
Intervention: Midwife-led brief counseling intervention
Number of subjects: 90

Group type: COMPARATOR
Intervention: Postnatal routine care (Control)
Number of subjects: 90
Study: 35085831

Group type: EXPERIMENTAL
Intervention: Treatment T
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reference treatment R
Number of subjects: 0
Study: 34793640

Group type: EXPERIMENTAL
Intervention: Combination paracetamol iv (1 g) and ibuprofen iv (800 mg)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Paracetamol iv only (1 g)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Ibuprofen iv only (800 mg)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Combination paracetamol iv and ibuprofen iv
Number of subjects: 36

Group type: COMPARATOR
Intervention: Paracetamol iv only
Number of subjects: 36

Group type: COMPARATOR
Intervention: Ibuprofen iv only
Number of subjects: 36
Study: 34077032

Group type: EXPERIMENTAL
Intervention: Lemborexant
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lemborexant 5 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lemborexant 10 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Other hypnotics (indirect comparison)
Number of subjects: 0
Study: 35751180

Group type: EXPERIMENTAL
Intervention: Modified CARELINK programme (multicomponent intervention with 6 home-based sessions and 5 telephone calls)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Modified CARELINK programme (multicomponent intervention)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 119
Study: 33545983

Group type: EXPERIMENTAL
Intervention: Femoral nerve block (FNB) with epidural anesthesia
Number of subjects: 41

Group type: COMPARATOR
Intervention: Epidural anesthesia only (Control group)
Number of subjects: 41
Study: 36107990

Group type: EXPERIMENTAL
Intervention: Aerobic Exercise Training (AET)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Stretching and Toning (SAT)
Number of subjects: 73
Study: 34820153

Group type: EXPERIMENTAL
Intervention: Lavender Aromatherapy (LA)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo (water)
Number of subjects: 62
Study: 34467453

Group type: EXPERIMENTAL
Intervention: Gadoxetic acid–enhanced MRI
Number of subjects: 359
Study: 33857496

Group type: EXPERIMENTAL
Intervention: HeartMate III (HM3)
Number of subjects: 569

Group type: COMPARATOR
Intervention: Heartware HVAD
Number of subjects: 569
Study: 34014472

Group type: EXPERIMENTAL
Intervention: Spiritual counseling (3 sessions of group counseling)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 56
Study: 32440977

Group type: EXPERIMENTAL
Intervention: Dexamethasone 0.1% ophthalmic suspension
Number of subjects: 75

Group type: COMPARATOR
Intervention: Bromfenac 0.09% ophthalmic solution
Number of subjects: 75
Study: 35555888

Group type: EXPERIMENTAL
Intervention: High dose oral FeSO4 (150-200 mg) for 8 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Heme-iron-polypeptide (HIP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (plasma from participants without obesity or bariatric surgery)
Number of subjects: 0
Study: 33871211

Group type: EXPERIMENTAL
Intervention: Weekly 300 mg azathioprine (n = 40)
Number of subjects: 80

Group type: COMPARATOR
Intervention: 15 mg methotrexate every week (n = 40)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 80
Study: 34493130

Group type: EXPERIMENTAL
Intervention: Probiotic supplementation with Bifidobacterium Lactis BS01 and Lactobacillus Acidophilus LA02 for 6 weeks
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo treatment for 6 weeks
Number of subjects: 53
Study: 33269889

Group type: EXPERIMENTAL
Intervention: Face Pain Scale
Number of subjects: 117

Group type: COMPARATOR
Intervention: Borg Scale
Number of subjects: 117
Study: 33400433

Group type: COMPARATOR
Intervention: Two injections from two planes (Group C)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Two injections in one plane (Group E)
Number of subjects: 70
Study: 32964512

Group type: EXPERIMENTAL
Intervention: Supersaturated calcium phosphate rinse
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Extra-soft toothbrush with control regimen
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control regimen (0.12% chlorhexidine gluconate + 3% sodium bicarbonate + nystatin 5000 U/mL)
Number of subjects: 45
Study: 35565911

Group type: EXPERIMENTAL
Intervention: Normal Weight (NW)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Over Weight (OW)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Both groups (NW and OW)
Number of subjects: 176
Study: 33326047

Group type: EXPERIMENTAL
Intervention: Vitamin C and growth factors (GFs)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Vitamin C only
Number of subjects: 149
Study: 33512013

Group type: EXPERIMENTAL
Intervention: ddPCR
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: RT-qPCR
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: ddPCR and RT-qPCR
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: RT-qPCR and ddPCR
Number of subjects: 90
Study: 35057578

Group type: EXPERIMENTAL
Intervention: Low FODMAP diet
Number of subjects: 67

Group type: COMPARATOR
Intervention: Traditional IBS diet
Number of subjects: 67
Study: 32198861

Group type: EXPERIMENTAL
Intervention: Phenytoin (20 mg/kg over 20 minutes)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Valproate (20 mg/kg over 20 minutes)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Levetiracetam (20 mg/kg over 20 minutes)
Number of subjects: 110
Study: 36031787

Group type: EXPERIMENTAL
Intervention: 1/4‐inch soft plastazote (SP) flat insole
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Metatarsal pad positioned proximal to the metatarsal head (MTH) on the control insole (P0)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Metatarsal pad positioned 10 mm distal from the proximal border of the MTH on the control insole (P10)
Number of subjects: 16

Group type: COMPARATOR
Intervention: 1/16‐inch insole (control)
Number of subjects: 16
Study: 32342846

Group type: EXPERIMENTAL
Intervention: Mass testing and treatment (MTaT) of malaria infections, tested three times per year for two years, treated with dihydroartemisinin-piperaquine.
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (20 clusters where MTaT was not implemented).
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Mass testing and treatment (MTaT) of malaria infections.
Number of subjects: 10
Study: 35999074

Group type: EXPERIMENTAL
Intervention: Size 2 GlideScope® blade
Number of subjects: 60

Group type: COMPARATOR
Intervention: Size 1 GlideScope® blade
Number of subjects: 60
Study: 36068131

Group type: EXPERIMENTAL
Intervention: Vocal therapy with TENS (12 sessions of 20 min, pulse: 200μs, frequency: 10Hz) followed by vocal exercises (30 min)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo TENS (12 sessions of 20 min, same conditions as EG but without electric stimulus) followed by vocal exercises (30 min)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Vocal therapy with TENS followed by vocal exercises
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo TENS followed by vocal exercises
Number of subjects: 27

Group type: COMPARATOR
Intervention: Vocal therapy without TENS
Number of subjects: 27
Study: 35584874

Group type: EXPERIMENTAL
Intervention: Assisted vaginal delivery
Number of subjects: 3594

Group type: EXPERIMENTAL
Intervention: Delivery by caesarean section
Number of subjects: 3594

Group type: EXPERIMENTAL
Intervention: Maternal health problems during childbirth
Number of subjects: 3594

Group type: EXPERIMENTAL
Intervention: Preterm newborns
Number of subjects: 3594

Group type: EXPERIMENTAL
Intervention: Newborns moved slowly immediately after birth
Number of subjects: 3594

Group type: EXPERIMENTAL
Intervention: Sick newborns
Number of subjects: 3594
Study: 34190197

Group type: EXPERIMENTAL
Intervention: TXA, systemic, repeated 1 g bolus
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: TXA, topically intra-articularly, 2 g in 50 mL saline
Number of subjects: 123

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 123
Study: 32774652

Group type: EXPERIMENTAL
Intervention: STOPBANG score at threshold 3
Number of subjects: 3033

Group type: EXPERIMENTAL
Intervention: STOPBANG score
Number of subjects: 3033
Study: 36472034

Group type: EXPERIMENTAL
Intervention: TQHXD‐CSF
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TQHXD‐CSF+si‐ASK1
Number of subjects: 0

Group type: COMPARATOR
Intervention: OGD/R
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Z‐VAD‐FMK (20 μmol·L(‐1))
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: si‐ASK1
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (blank cerebrospinal fluid)
Number of subjects: 0
Study: 33200488

Group type: EXPERIMENTAL
Intervention: 80 mg nanocurcumin daily for 12 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 37773192

Group type: EXPERIMENTAL
Intervention: Exposure to post-doctoral researcher (n=151)
Number of subjects: 630

Group type: COMPARATOR
Intervention: No exposure to post-doctoral researcher (n=164)
Number of subjects: 630

Group type: EXPERIMENTAL
Intervention: Exposure to supervisor (n=155)
Number of subjects: 630

Group type: COMPARATOR
Intervention: No exposure to supervisor (n=160)
Number of subjects: 630
Study: 34406619

Group type: EXPERIMENTAL
Intervention: Abrocitinib 200 mg
Number of subjects: 2856

Group type: EXPERIMENTAL
Intervention: Abrocitinib 100 mg
Number of subjects: 2856

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2856
Study: 32498932

Group type: EXPERIMENTAL
Intervention: Patient-centered intervention including the cumulative-complexity model
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (leaflet with information)
Number of subjects: 44
Study: 33236105

Group type: EXPERIMENTAL
Intervention: RenalGuard® (RG) system
Number of subjects: 220

Group type: COMPARATOR
Intervention: Current practice (control)
Number of subjects: 220
Study: 35689272

Group type: EXPERIMENTAL
Intervention: 12 weeks of rifapentine and isoniazid (3HP)
Number of subjects: 3000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3000
Study: 34658706

Group type: EXPERIMENTAL
Intervention: Microneedling alone (MN)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Chemical peeling alone (CP)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Combination of microneedling and chemical peeling (MN + CP)
Number of subjects: 120
Study: 35129994

Group type: EXPERIMENTAL
Intervention: Brief computerized intervention targeting distress intolerance (DI)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Acute stress enhancement of the cannabis LPP
Number of subjects: 60
Study: 33887209

Group type: EXPERIMENTAL
Intervention: Low-dose (1.3 µg) plus AF03
Number of subjects: 441

Group type: EXPERIMENTAL
Intervention: Low-dose (1.3 µg) plus AS03
Number of subjects: 441

Group type: EXPERIMENTAL
Intervention: High-dose (2.6 µg) plus AF03
Number of subjects: 441

Group type: EXPERIMENTAL
Intervention: High-dose (2.6 µg) plus AS03
Number of subjects: 441

Group type: EXPERIMENTAL
Intervention: Unadjuvanted high-dose (2.6 µg)
Number of subjects: 441

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 441
Study: 32050996

Group type: EXPERIMENTAL
Intervention: Health star rating
Number of subjects: 2008

Group type: COMPARATOR
Intervention: Control (NFt)
Number of subjects: 2008

Group type: EXPERIMENTAL
Intervention: Traffic light
Number of subjects: 2008

Group type: EXPERIMENTAL
Intervention: 'High-in' warning labels
Number of subjects: 2008
Study: 36344308

Group type: EXPERIMENTAL
Intervention: Device-guided slow breathing (SDB)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Sham control breathing
Number of subjects: 17
Study: 33651033

Group type: COMPARATOR
Intervention: Ultrasonic cleaning in distilled water (Group B)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Ultrasonic bath with a special detergent solution (Group C)
Number of subjects: 24

Group type: COMPARATOR
Intervention: No additional cleaning (Group A)
Number of subjects: 24
Study: 32227771

Group type: EXPERIMENTAL
Intervention: Yiqi Huoxue Jiedu decoction (YHJD)
Number of subjects: 330

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 330
Study: 36174163

Group type: EXPERIMENTAL
Intervention: Questionnaire with 30 items
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Questionnaire with 60 items
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Three assessments per day
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Six assessments per day
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Nine assessments per day
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Experience Sampling Method (ESM)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Qualitative interviews
Number of subjects: 151
Study: 34137526

Group type: EXPERIMENTAL
Intervention: Empagliflozin 10mg twice a day
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study: 34767495

Group type: EXPERIMENTAL
Intervention: Inhaled treprostinil
Number of subjects: 326

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 326
Study: 32918964

Group type: EXPERIMENTAL
Intervention: Resolution of macular edema (ME)
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Epiretinal membranes on OCT
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Resolved ME
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Eyes that did not resolve ME
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Eyes that developed ME during the year (incident or relapsed)
Number of subjects: 177
Study: 34549258

Group type: EXPERIMENTAL
Intervention: 10 mg enalapril and 0.8 mg folic acid
Number of subjects: 20702

Group type: COMPARATOR
Intervention: 10 mg enalapril alone
Number of subjects: 20702
Study: 32690472

Group type: EXPERIMENTAL
Intervention: DHA treatment (2,152 mg of DHA per day)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 36222597

Group type: EXPERIMENTAL
Intervention: Once-weekly semaglutide
Number of subjects: 0
Study: 34470656

Group type: EXPERIMENTAL
Intervention: DICA Br supplemented with 30 g/day of mixed nuts (10 g of peanuts, 10 g of cashew, 10 g of Brazil nuts)
Number of subjects: 388

Group type: COMPARATOR
Intervention: Only DICA Br
Number of subjects: 388

Group type: EXPERIMENTAL
Intervention: DICA Br supplemented with mixed nuts
Number of subjects: 388
Study: 33181580

Group type: EXPERIMENTAL
Intervention: Terbutaline (5-15 mg)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Imipramine (30-150 mg)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 32071919

Group type: EXPERIMENTAL
Intervention: Micrografts containing human hair follicle mesenchymal stem cells (HF‐MSCs)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 34687483

Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine solution
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: 1% chlorhexidine solution
Number of subjects: 116

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 116
Study: 32059924

Group type: EXPERIMENTAL
Intervention: Concurrent Treatment of PTSD and Substance Use Disorders using Prolonged Exposure (COPE)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Relapse Prevention Therapy (RPT)
Number of subjects: 82
Study: 35552156

Group type: EXPERIMENTAL
Intervention: Gamification technique
Number of subjects: 15

Group type: COMPARATOR
Intervention: Case Based Learning (CBL)
Number of subjects: 15
Study: 33196289

Group type: EXPERIMENTAL
Intervention: Paraffin bath therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (routine skin care program only)
Number of subjects: 60
Study: 33878065

Group type: EXPERIMENTAL
Intervention: Photochromic contact lens (activated)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Photochromic contact lens (inactivated)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Nonphotochromic contact lens (control)
Number of subjects: 54
Study: 32045025

Group type: EXPERIMENTAL
Intervention: Family Nurse Partnership (FNP) intervention
Number of subjects: 483

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 483
Study: 35410312

Group type: EXPERIMENTAL
Intervention: TASC intervention (telehealth-enabled multidisciplinary stroke care)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Usual care (primary care nurse practitioner and stroke neurologist visits)
Number of subjects: 50
Study: 32164653

Group type: EXPERIMENTAL
Intervention: Usual Care (UC)
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Prediction model with kinesiophobia
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Prediction model without kinesiophobia
Number of subjects: 170
Study: 36214072

Group type: EXPERIMENTAL
Intervention: QIVc
Number of subjects: 1667

Group type: COMPARATOR
Intervention: QIV
Number of subjects: 1667